Patient outcomes from implementing an enhanced services pharmacy network.

Journal of the American Pharmacists Association : JAPhA
Benjamin Y UrickJoel F Farley

Abstract

To evaluate the effect of implementing a network of community pharmacies on medication adherence, health service utilization, and health care spending. Quasi-experimental difference-in-difference analysis with a nonequivalent control group. Eligible Medicaid-enrolled patients in North Carolina were attributed to intervention pharmacies between March 2015 and December 2016. A control group was propensity score-matched. Interventions consisted of enhanced services and a more intensive, comprehensive initial pharmacy assessment (CIPA). Outcomes included hospitalizations; emergency department (ED) visits; health care spending for total medical, inpatient, outpatient, and ED services; and adherence to renin-angiotensin system antagonists (RASA), statins, noninsulin diabetes medications (NIDM), and multiple medications for chronic conditions (MMCC). There were 31,509 patients who met eligibility criteria and were attributed to a participating pharmacy. Of these, 3897 received a CIPA. Before matching, patients attributed to participating pharmacies had greater Medicaid enrollment through aged, blind, or disabled status (49.2% vs. 31.5%, P < 0.001); greater case management (10.3% vs. 7%, P < 0.001); and worse rates of chronic disease (...Continue Reading

References

Mar 24, 2000·Journal of the American Pharmaceutical Association : APhA·B M BlumlM J Cziraky
Feb 24, 2001·Journal of the American Geriatrics Society·J T HanlonM Weinberger
Apr 4, 2003·JAMA : the Journal of the American Medical Association·David N JuurlinkDonald A Redelmeier
Apr 12, 2003·Journal of the American Pharmaceutical Association : APhA·Carole W Cranor, Dale B Christensen
Apr 12, 2003·Journal of the American Pharmaceutical Association : APhA·Carole W CranorDale B Christensen
Apr 22, 2004·Journal of the American Pharmacists Association : JAPhA·Jean-Venable GoodeBenjamin M Bluml
Apr 28, 2004·Diabetes Care·Joyce A Cramer
May 5, 2005·Journal of the American Pharmacists Association : JAPhA·Daniel G Garrett, Benjamin M Bluml
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Sep 27, 2006·Archives of Internal Medicine·P Michael HoJohn S Rumsfeld
Dec 26, 2006·Pharmacy World & Science : PWS·Matthijs L BeckerBruno H Ch Stricker
Jul 16, 2008·Annals of Family Medicine·Beat D SteinerL Allen Dobson
Sep 12, 2008·Health Services Research·Bruce C StuartJoseph V Terza
Sep 26, 2008·Journal of General Internal Medicine·Jacquelyn S HuntDaniel Touchette
Apr 10, 2009·Journal of the American Pharmacists Association : JAPhA·Toni FeraWilliam M Ellis
May 5, 2010·Health Affairs·Marie SmithPaul D Cleary
Aug 20, 2010·Medical Care·Marie A Chisholm-BurnsTimothy Wunz
Jan 21, 2011·Journal of the American Pharmacists Association : JAPhA·Patrick R FinleyStephanie N Kiser
Apr 8, 2011·Health Affairs·Marie SmithMichael P Starkowski
Mar 7, 2012·Pharmacotherapy·Theresa L CharroisRoss T Tsuyuki
May 31, 2012·Drugs & Aging·Antonio CherubiniFabrizia Lattanzio
Nov 9, 2012·Evidence-based Medicine·Ian A ScottCharles A Mitchell
Nov 6, 2013·Health Affairs·Marie SmithThomas S Bodenheimer
Nov 18, 2014·JAMA Internal Medicine·Meera ViswanathanKathleen N Lohr
Dec 10, 2014·Research in Social & Administrative Pharmacy : RSAP·Jonathan Hirohiko Watanabe, John P Ney
Mar 24, 2015·JAMA Internal Medicine·Ian A ScottJennifer H Martin
May 12, 2015·Medical Care·Bruce C StuartJulia S Dougherty
Sep 12, 2015·Health Affairs·M Christopher RoebuckLaura M Miller
Feb 9, 2017·Journal of the American Pharmacists Association : JAPhA·Megan G SmithStefanie P Ferreri
Feb 9, 2017·Journal of the American Pharmacists Association : JAPhA·Megan G SmithTrista M Pfeiffenberger
Mar 27, 2018·The Annals of Pharmacotherapy·Jonathan H WatanabeJan D Hirsch
Feb 5, 2019·Journal of the American Pharmacists Association : JAPhA·Benjamin Y Urick, Joel F Farley
Mar 5, 2019·Journal of the American Pharmacists Association : JAPhA·Chelsea Phillips RenfroStefanie P Ferreri
Jul 5, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Joel F FarleyBenjamin Y Urick

❮ Previous
Next ❯

Citations

Mar 2, 2021·Journal of Managed Care & Specialty Pharmacy·Benjamin Y UrickStefanie P Ferreri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Pharmacists Association : JAPhA
Chelsea Phillips RenfroStefanie P Ferreri
Journal of the American Pharmacists Association : JAPhA
Benjamin Y Urick, Joel F Farley
© 2021 Meta ULC. All rights reserved